NIH funding changes threaten Pittsburgh's biomedical research, risking jobs, innovation and future medical breakthroughs, ...
A new initiative rolled out under President Donald Trump’s administration is cutting billions from grants for "indirect costs" tied to biomedical research, such as facilities, equipment and ...
A de facto funding freeze on federal biomedical grants could soon stymie UC Santa Cruz research and stifle the county’s biotech industry, ...
Puma Biotech (PBYI) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.31 per share a year ago. These figures ...
ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company focused on innovative treatments in ...